
Biomednewsbreaks Heartbeam Inc. (NASDAQ: BEAT) Hits FDA Milestone And Expands Strategic Partnerships In Q1 Update
(MENAFN- Investor Brand Network) HeartBeam (NASDAQ: BEAT) reported Q1 2025 results highlighted by successful completion of the VALID-ECG pivotal study, supporting its 510(k) submission for 12-lead ECG synthesis software and confirming productive ongoing …